Jilin Zixin Pharmaceutical Co., Ltd. and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- According to Article 9.2.1 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," as of June 6, 2023, the company's stock closing price was 0.52 CNY/share, and it has been below 1 CNY for thirteen consecutive trading days. Even if the stock experiences a price increase for the next seven trading days, it will still trigger the delisting criteria due to being below 1 CNY for twenty consecutive trading days. If this occurs, the Shenzhen Stock Exchange will make a decision to terminate the listing within the stipulated timeframe, and the stock will not enter a delisting adjustment period.
- According to Article 9.2.3 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," the company must disclose the risk warning regarding the potential termination of listing due to the stock price being below par value. This warning will be disclosed daily until the situation is resolved or until the Shenzhen Stock Exchange makes a decision to terminate the listing. Investors are advised to invest rationally and pay attention to risks.